Company Clover Biopharmaceuticals, Ltd.

Equities

2197

KYG2280A1076

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Quarterly revenue - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - Hong Kong S.E. Other stock markets 09:08:22 29/04/2024 BST			5-day change	1st Jan Change
0.345 ^HKD	-4.17%		+4.55%	-44.35%

04-12	Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding	CI
04-08	Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial	MT

Clover Biopharmaceuticals Ltd is a China-based company mainly engaged in pharmaceutical business. The Company's main business is the development of new vaccines and biotherapeutic candidates for infectious diseases, cancer and autoimmune diseases. The Company's products are mainly used to treat the new coronavirus, malignant ascites, and ankylosing spondylitis.

Number of employees: 387

Managers	Title	Age	Since
Joshua Liang CEO	Chief Executive Officer	-	24/12/20
Aileen Wang DFI	Director of Finance/CFO	-	28/02/21
Htay Htay Han CTO	Chief Tech/Sci/R&D Officer	56	02/02/21
Wang Xiaoyan SEC	Corporate Secretary	-	30/03/23
Lily Yang HRO	Human Resources Officer	-	30/04/21
Liong Ho Chua PRN	Corporate Officer/Principal	60	26/04/22
Xiao Bing Li PRN	Corporate Officer/Principal	56	26/07/20
Hing Ling Chau SEC	Corporate Secretary	49	21/12/21

Members of the board	Title	Age	Since
Jeffrey Farrow BRD	Director/Board Member	62	18/04/21
Xiao Dong Wang BRD	Director/Board Member	61	15/03/21
Xiao Bin Wu BRD	Director/Board Member	62	18/04/21
Donna Ambrosino BRD	Director/Board Member	72	16/06/22
Ralf Clemens BRD	Director/Board Member	71	16/06/22
Thomas Leggett BRD	Director/Board Member	47	18/04/21
Peng Liang CHM	Chairman	63	30/10/18
Joshua Liang CEO	Chief Executive Officer	-	24/12/20
Xiang Liao BRD	Director/Board Member	59	18/04/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,296,995,429	634,387,467 ( 48.91 %)	0	48.91 %

Name	Equities	%	Valuation
Peng Liang 16.17 %	209,702,153	16.17 %	11 M $
Hillhouse Investment Management Ltd. (Invest) 12.69 %	164,593,429	12.69 %	9 M $
Super Novel International Ltd. 4.965 %	64,388,742	4.965 %	3 M $
Temasek Capital Pte Ltd. 4.474 %	58,021,257	4.474 %	3 M $
Xiao Dong Wang 2.182 %	28,300,750	2.182 %	1 M $
Joshua Liang 1.580 %	20,489,909	1.580 %	1 M $
Bosera Asset Management Co., Ltd. 0.4685 %	6,076,000	0.4685 %	318 322 $
Ralf Clemens 0.0530 %	687,452	0.0530 %	36 016 $
Jeffrey Farrow 0.0232 %	300,750	0.0232 %	15 756 $
Xiao Bin Wu 0.0232 %	300,750	0.0232 %	15 756 $

Clover Biopharmaceuticals Ltd.

49F, Park Place 1598-1601 West Nanjing Road

200010, Shanghai

http://www.cloverbiopharma.com

address Clover Biopharmaceuticals, Ltd.(2197)

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
CLOVER BIOPHARMACEUTICALS, LTD.	-44.35%	59.65M
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+0.61%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-8.56%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.73B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B

Bio Therapeutic Drugs